Backed by GV.
About the role
The Vice President, Early Discovery Chemistry will report to the Senior Vice President of Medicinal Chemistry and Screening Platform Technologies and serve as the scientific and organizational leader for Revolution Medicines' Early Discovery Chemistry organization. The role will lead multidisciplinary teams spanning Early Discovery Chemistry, Analytical Chemistry, library sciences, and enabling discovery technologies to drive the identification of novel chemical matter for Revolution Medicines' oncology pipeline.
What they're looking for
- Ph.D. in Organic Chemistry, Medicinal Chemistry, or related discipline
- 15+ years of industrial drug discovery experience with significant leadership responsibility in Early Discovery or Medicinal Chemistry
- Demonstrated success leading programs from target concept through hit identification and into lead optimization
- Hit identification, Library design and chemical diversity, Fragment-based drug discovery, Screening technologies, Computationally enabled molecular design
- Building and leading multidisciplinary scientific organizations
- Strong strategic leadership experience including organizational design, budgeting, hiring, and talent development
More about this role
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Vice President, Early Discovery Chemistry will report to the Senior Vice President of Medicinal Chemistry and Screening Platform Technologies and serve as the scientific and organizational leader for Revolution Medicines' Early Discovery Chemistry organization. The role will lead multidisciplinary teams spanning Early Discovery Chemistry, Analytical Chemistry, library sciences, and enabling...
Browse similar: Startup jobs · San Francisco Bay Area